Axsome Therapeutics, Inc. (AXSM)
161.44
-2.64
(-1.61%)
USD |
NASDAQ |
Mar 05, 16:00
161.44
0.00 (0.00%)
After-Hours: 20:00
Axsome Therapeutics Free Cash Flow : -93.88M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 141.78M |
| Gilead Sciences, Inc. | 9.456B |
| Vanda Pharmaceuticals, Inc. | -110.44M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Amicus Therapeutics, Inc. | 29.85M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.65M |
| Cash from Investing (Quarterly) | -0.071M |
| Cash from Financing (Quarterly) | 16.38M |
| Free Cash Flow Per Share (Quarterly) | -0.3698 |
| Free Cash Flow to Equity (Quarterly) | -18.24M |
| Free Cash Flow to Firm (Quarterly) | -15.47M |
| Free Cash Flow Yield | -1.17% |